Regional hyperinsulinemia induces vasodilation but does not modulate adrenergic responsiveness in humans

Journal of Cardiovascular Pharmacology

Volumn 28, Issue 2, 1996, Pages 245-251

  Tack, Cees J J ^a   Heeremans, Marian ^a   Thien, Theo ^a   Lutterman, Jos A ^a   Smits, Paul ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adrenoceptor; Adrenoceptor; Insulin; Vasodilation

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; INSULIN; ISOPRENALINE; NORADRENALIN; PROPRANOLOL;

ADRENERGIC SYSTEM; ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; INSULIN RESISTANCE; MALE; MUSCLE BLOOD FLOW; PRIORITY JOURNAL; VASOCONSTRICTION; VASODILATATION;

ADULT; BLOOD GLUCOSE; FEMALE; HUMANS; HYPERINSULINISM; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRAVENOUS; INSULIN; MALE; MUSCLE, SKELETAL; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, ADRENERGIC, BETA; REGIONAL BLOOD FLOW; SYMPATHETIC NERVOUS SYSTEM; VASODILATION;

EID: 0029748624     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199608000-00010     Document Type: Article

References (41)

1. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94.
2. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
3. Dinneen S, Gerich J, Rizza R. Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med 1992;327:707-13.
4. Anderson EA, Mark AL. The vasodilator action of insulin. Implications for the insulin hypothesis of hypertension. Hypertension 1993;21:136-41.
5. Reaven GM. Insulin resistance, hyperinsulinemia, hypertriglyceridemia and hypertension. Parallels between human disease and rodent models. Diabetes Care 1991;14:195-202.
6. Rowe JW, Young JB, Minaker KL, Stevens AL, Palotta JA, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981;30:219-25.
7. Hall JE, Brands MW, Kivlighn SD, Mizelle HL, Hildebrandt DA, Gaillard CA. Chronic hyperinsulinemia and blood pressure. Interaction with catecholamines? Hypertension 1990; 15:519-27.
8. Hulthen UL, Endre T, Mattiasson I, Berglund G. Insulin and forearm vasodilation in hypertension-prone men. Hypertension 1995;25:214-8.
9. Anderson EA, Hoffmann RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991;87:2246-52.
10. Utriainen T, Malmström R, Mäkimattila S, Yki-Järvinen H. Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects. Diabetologia 1995;38: 555-64.
11. Anderson EA, Balon TW, Hoffmann RP, Sinkey CA, Mark AL. Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension 1992;19:621-7.
12. Tack CJJ, Smits P, Willemsen JJ, Lenders JWM, Thien Th, Lutterman JA. Effects of insulin on vascular tone and sympathetic nervous system in NIDDM. Diabetes 1996;45:15-22.
13. Berne C, Fagius J, Pollare T, Hjemdahl P. The sympathetic response to euglycemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects. Diabetologia 1992;35:873-9.
14. Jern S. Effects of insulin on vascular responses to mental stress and norepinephrine in human forearm. Hypertension 1994;24:686-94.
15. Yagi S, Takata S, Kiyokawa H, Yamamoto M, Noto Y, Ikeda T, Hattori N. Effects of insulin on vasoconstrictive responses to norepinephrine and angiotensin II in rabbit femoral artery and vein. Diabetes 1988;37:1064-67.
16. Gans ROB, Bilo HJG, Maarschalkerweerd WWAV, Heine RJ, Nauta JJP, Donker AJM. Exogenous insulin augments in healthy volunteers the cardiovascular reactivity to noradrenaline but not to angiotensin II. J Clin Invest 1991;88:512-8.
17. Egan B, Panis R, Hinderliter A, Schork N, Julius S. Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest 1987;80:812-7.
18. Sakai K, Imaizumi T, Masaki H, Takeshita A. Intra-arterial infusion of insulin attenuates vasoreactivity in human forearm. Hypertension 1993;22:67-73.
19. Rocchini AP, Moorehead C, DeRemer S, Goodfriend ThL, Ball DL. Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II. Hypertension 1990;15:861-6.
20. Neahring JM, Stepniakowski K, Greene AS, Egan B. Insulin does not reduce forearm α-vasoreactivity in obese hypertensive or lean normotensive men. Hypertension 1993;22:584-90.
21. Townsend RR, Yamamoto R, Nickols M, DiPette DJ, Nickols GA. Insulin enhances pressor responses to norepinephrine in rat mesenteric vasculature. Hypertension 1992;19 (suppl II):II-105-110.
22. Alexander WD, Oake RJ. The effect of insulin on vascular reactivity to norepinephrine. Diabetes 1977;26:611-4.
23. Yamamoto M, Asayama K, Kanai M, et al. Effects of insulin on vasoconstrictor responses to alpha agonist and tilting. Angiology 1990;41:394-400.
24. Gros R, Borkowski KR, Feldman RD. Human insulin-mediated enhancement of vascular β-adrenergic responsiveness. Hypertension 1994;23:551-5.
25. Stein CM, Nelson R, Deegan R, He H, Wood M, Wood AJJ. Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spill-over, in borderline hypertension. J Clin Invest 1995;96:579-85.
26. Lager I, Attval S, Eriksson BM, von Schenk H, Smith U. Studies on the insulin-antagonistic effect of catecholamines in normal man. Evidence for the importance of β2-receptors. Diabetologia 1986;29:409-16.
27. Lembo G, Napoli R, Capaldo B, et al. Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. J Clin Invest 1992; 90:24-9.
28. Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 1995;25: 918-23.
29. Gans ROB, Bilo HJG, Nauta JJP, Heine RJ, Donker AJM. Acute hyperinsulinemia induces sodium retention and a blood pressure decline in diabetes mellitus. Hypertension 1992:20:199-209.
30. Lembo G, Rendina V, laccarino G, Lamenza F, Volpe M, Trimarco B. Insulin reduces reflex forearm sympathetic vasoconstriction in healthy humans. Hypertension 1993;21: 1015-9.
31. Starke K. Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 1977; 77:1-24.
32. 2-adrenoceptor mediated vasoconstriction in the forearm of normotensive and hypertensive subjects. J Cardiovasc Pharmacol 1986;8: 190-6.
33. Calver A, Collier J. Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 1992; 90:2548-54.
34. Vatner SF, Knight DR. Hintze TH. Norepinephrine-induced β1-adrenergic peripheral vasodilation in conscious dogs. Am J Physiol 1985;249;H49-56.
35. Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest 1990;85:1844-52.
36. Baron AD, Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G. Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest 1995;96:786-92.
37. Steinberg HM, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilator is nitric oxide dependent. A novel action of insulin to increase nitric-oxide release. J Clin Invest 1994;94:1172-9.
38. Barcroft H, Gaskell P, Shepherd JT, Whelan RF. The effect of noradrenaline infusions on the blood flow through the human forearm. J Physiol 1954;123:443-50.
39. Creager MA, Liang C, Coffman JD. Beta adrenergic-mediated vasodilator respons to insulin in the human forearm. J Pharmacol Exp Ther 1985;235:709-14.
40. Baron AD, Brechtel-Hook G, Johnson AD, Hardin D, Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure. Hypertension 1993;21:129-35.
41. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin's effects in humans. J Clin Invest 1995;94:2511-15.